Resmed (RMD) Tax Provisions (2009 - 2026)

Resmed's Tax Provisions history runs 18 years deep, the most recent figure standing at $103.6 million for Q1 2026.

• Quarterly Tax Provisions rose 96.73% year-over-year to $103.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $383.7 million (up 45.36% YoY) and the FY2025 annual result came in at $276.8 million, up 13.53% from the prior year.
• Tax Provisions was $103.6 million for Q1 2026 at Resmed, roughly flat from $103.6 million in the prior quarter.
• Across five years, Tax Provisions topped out at $103.6 million in Q1 2026 and bottomed at $43.0 million in Q2 2022.
• A 5-year average of $65.9 million and a median of $56.9 million in 2023 frame the typical range for Tax Provisions.
• Annual changes were most pronounced in 2022 — Tax Provisions plunged 84.04% — and 2026, when it jumped 96.73%.
• Resmed's Tax Provisions stood at $48.8 million in 2022, then rose by 3.85% to $50.7 million in 2023, then surged by 45.5% to $73.7 million in 2024, then jumped by 40.51% to $103.6 million in 2025, then advanced by 0.02% to $103.6 million in 2026.
• Business Quant data shows RMD's Tax Provisions at $103.6 million in Q1 2026, $103.6 million in Q4 2025, and $98.3 million in Q3 2025.